Anaphylatoxin
Top View
- Contribution of Complement Anaphylatoxin Receptors to Melanoma Growth: Potential Therapeutic Targets
- The Anaphylatoxin C3a Downregulates the Th2 Response to Epicutaneously Introduced Antigen
- Targeting Complement Component 5A Promotes Vascular Integrity and Limits Airway Remodeling
- Anaphylatoxin Inactivator of Human Plasma: Its Isolation and Characterization As a Carboxypeptidase
- C4a Anaphylatoxin
- The Complement System
- Monitoring C3ar Expression Using a Floxed Tdtomato-C3ar Reporter Knock-In Mouse
- Clinical Basis of the Immune Response and the Complement Cascade
- Classical Complement Pathway
- Anti-Complement C3 (Alpha Chain, Anaphylatoxin) Antibody [7C1] (ARG10708)
- Migration in Vivo and Impairs Anaphylatoxin-Induced Receptors in Monocytes and Dendritic Cells IL-4 Down-Regulates Anaphylatoxin
- Isolation and Characterization of a C4-Like Complement Protein from Chicken Plasma Woan-Hwa Renee Lee Iowa State University
- Structural Basis for the Function of Complement Component C4 Within the Classical and Lectin Pathways of Complement
- Innate Immunity and Resistance to Tolerogenesis in Allotransplantation
- Complement Determinations in Human Disease M
- Classical and Lectin Pathways Blocks Complement Activation Via the Alkaline Protease Pseudomonas Aeruginosa
- In Alloimmunity and Transplantation
- Over-Activation of Anaphylatoxin–Neutrophil Extracellular Trap Axis in COVID-19 Patients